Home/Aurobindo Pharma/Govindarajan V.
GV

Govindarajan V.

Chief Financial Officer

Aurobindo Pharma

Aurobindo Pharma Pipeline

DrugIndicationPhase
US Generics PortfolioBroad Therapeutic AreasFiled/Approved
Biosimilars Pipeline (Oncology Focus)OncologyDevelopment
Biosimilars Pipeline (Immunology Focus)ImmunologyDevelopment
Complex Generics PipelineVariousDevelopment/Filed
ARV PortfolioHIV/AIDSCommercial